Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease

Atrial fibrillation and coronary artery disease are commonly coexisting conditions that necessitate the use of an oral anticoagulant as well as dual antiplatelet therapy. Commonly referred to as triple oral antithrombotic therapy (TT), this helps prevent ischemic stroke and myocardial infarction but...

Descripción completa

Detalles Bibliográficos
Autores principales: Moustafa, Abdelmoniem, Ruzieh, Mohammad, Eltahawy, Ehab, Karim, Saima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796304/
https://www.ncbi.nlm.nih.gov/pubmed/31903386
http://dx.doi.org/10.4103/ajm.AJM_73_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796304/
https://www.ncbi.nlm.nih.gov/pubmed/31903386
http://dx.doi.org/10.4103/ajm.AJM_73_19

Ejemplares similares